Abstract
We have previously shown that galectin-1 is a factor capable of converting mouse dermal fibroblasts to the myogenic lineage [Cell Transplant 2000;9:519]. Here, we report that human dermal fibroblasts are also capable of expressing the myogenic marker, desmin, when grown in muscle-cell-conditioned media. Furthermore, the human foetal skin cells also express this marker when grown in the presence of galectin-1. These results highlight the importance of galectin-1 in the conversion of both human and murine skin cells to a myogenic lineage. Thus galectin-1 could be an important tool for use in autologous cell therapies for the treatment of human muscular dystrophies. (C) 2002 Elsevier Science B.V. All rights reserved.
Original language | English |
---|---|
Pages (from-to) | 183 - 186 |
Number of pages | 4 |
Journal | Neuromuscular Disorders |
Volume | 12 |
Issue number | 2 |
DOIs | |
Publication status | Published - 2002 |